Summary
In order to determine in what condition and by what mechanism gp 120 can deplete not only CD4 but also CD8 T cells, an in vitro system was established in which peripheral blood lymphocytes from healthy donors were treated with recombinant gp 120. We found that gp 120 can deplete both CD4 and CD8 T cells when they have recently been activated and are exposed to IL-2-deficient conditions. Bioassay of the Fas ligand (FasL) demonstrated augmented expression and release of soluble FasL by CD4 T cells in the supernatant of this culture. The administration of anti-FasL mAb and anti-Fas mAb, both of which exhibit neutralizing activity, completely abolished the depletion of these two T cell populations in culture. Based on these findings, we concluded that FasL depletes Fas antigen expressing CD4 and CD8 T cells by programmed cell death.
Similar content being viewed by others
Author information
Authors and Affiliations
Additional information
Received December 18, 1996 Accepted May 2, 1997
Rights and permissions
About this article
Cite this article
Uchiyama, J., Kishi, S., Yagita, H. et al. Fas ligand-mediated depletion of CD4 and CD8 lymphocytesby monomeric HIV-1-gp120. Arch. Virol. 142, 1771–1785 (1997). https://doi.org/10.1007/s007050050196
Published:
Issue Date:
DOI: https://doi.org/10.1007/s007050050196